Admiration of the female colleagues of the Actover Pharmaceutical Group
In admiration of the dedication of our female colleagues at Actoverco Pharmaceutical Group, Mrs. Nahaleh NaraNaraghi expressed her appreciation for the esteemed women on the occasion of Women’s Day in Iran, through a heartfelt message.
The first specialized university in the field of geriatric care was opened
The opening ceremony of the specialized scientific-applied university for the care of the elderly, with the efforts of the Zinda charity in memory of the late Dr. Mustafa Naraghi, was held this morning during a ceremony at the Kehrizak nursing home with the presence of figures such as Dr. Haddad Adel, “Leadership Advisor”, Sardar Mohammadian, “Tehran Police Chief”, Dr. Shanehsaz, Dr. Izadi, Nahaleh Naraghi, and Dr. Alinasr Naraghi were held.
Senior managers of the Food and Drug Administration visit of Actover Group factories
According to the public relations of Actover Group, on Thursday, February 28, the senior managers of the Food and Drug Administration visited the factories of Actover Group.
Interview with the CEO of Actoverco
According to the public relations of Actover Group, Nahaleh Naraghi is the CEO of Actoverco. Actoverco is a leading company in the field of producing high quality drugs in accordance with the latest international standards.
Visit of neurologists and psychologists from Actoverco Pharmaceutical Factories
Actover Group, on the occasion of Doctor’s Day, hosted a group of prominent neurology and psychologist professors of Tehran on Thursday, August 22.
Signing agreement of cooperation and establishment of a new innovation center in the Actoverco company
Signing agreement of cooperation for the establishment of the “Actotech Innovation Center” and the beginning of the official knowledge-based activities in the Actoverco company was held in the presence of the Vice President for Science and Technology.
Actoverco received 90.8 million Euros of governmental currency in the first half of this year
The CEO of Actoverco said: “This Company has received about 90 million and 800 thousand Euros of governmental currency in the first 6 months of the year.”
With the lifting of sanctions, many announced their readiness to work with “Actoverco
We have a program for production of Rituximab and Bevacizumab drugs for cancer patients, ophthalmologists, etc. These drugs are very expensive due to their high technical knowledge, and from next year, we will also produce the raw materials for these drugs ourselves.